The DOI matches its Crossref record.
IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.
Abstract
Incubation of the human U937 histiocytic lymphoma cell line with granulocyte-macrophage colony stimulating factor (GM-CSF) rendered the cells responsive to induction of TNF by LPS. Treatment with IL-6 reduced TNF production in GM-CSF-primed U937 cells. The inhibitory effect was most pronounced (approximately equal to 80%) when IL-6 was added either along with GM-CSF or within the first 3 h of GM-CSF treatment. Both GM-CSF or IL-6 inhibited [3H]TdR uptake in U937 cells, and simultaneous treatment with GM-CSF and IL-6 resulted in an additive inhibitory effect on cell proliferation. However, the inhibition of TNF production could not be explained by the inhibitory effect of IL-6 on cell growth, nor was it due to a reduction in cell viability. An inhibition of TNF production by IL-6 was also demonstrated in cultured human peripheral blood monocytes. Treatment with IL-6 also resulted in a dose-dependent reduction of the 17-kDa TNF band revealed by SDS-PAGE after labeling monocytes with [35S]cysteine and immunoprecipitation with anti-TNF mAb. In addition, treatment with IL-6 resulted in a reduction of monocyte in vitro cytotoxicity for tumor target cells. Finally, in mice sensitized by the administration of Bacillus Calmette-Guérin, the injection of IL-6 significantly reduced the levels of TNF found in the serum upon challenge with LPS. Inasmuch as TNF is known to be an inducer of IL-6, the inhibitory action of IL-6 on TNF production may represent the negative arm of a regulatory circuit. The inhibitory action of IL-6 on TNF production is consistent with a predominantly antiinflammatory role of IL-6 in the intact organism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Application of acute phase protein measurements in veterinary clinical chemistry
Petersen, H. H., Nielsen, J. P., & Heegaard, P. M. H. (2004) · Veterinary Research · doi:10.1051/vetres:2004002 · Cited by 1,060
Inflammatory response to cardiopulmonary bypass
Butler, J., Rocker, G. M., & Westaby, S. (1993) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(93)91048-r · Cited by 1,033
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
Self-citationTilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Tumor necrosis factor in the heart
Meldrum, D. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r577 · Cited by 746
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore, M. A., Vilcek, J., Daddona, P., et al. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90106-l · Cited by 703
Self-citationIL-6 and APPs: anti-inflammatory and immunosuppressive mediators
Tilg, H., Dinarello, C. A., & Mier, J. W. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01103-1 · Cited by 633
Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action
Benveniste, E. N. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.1.c1 · Cited by 607
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
“Since IL-6 is known to downregulate TNF-a production in both in vitro and in vivo models of inflammation (29, 30), the development of arthritis in TIL-62/2 mice could be at least in part due to TNF-a upregulation in the absence of IL-6.”
BackgroundBone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199601000-00026 · Cited by 603
Crabtree, J. E., Shallcross, T. M., Heatley, R. V., & Wyatt, J. I. (1991) · Gut · doi:10.1136/gut.32.12.1473 · Cited by 547
Defective inflammatory response in interleukin 6-deficient mice.
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., & Poli, V (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1243 · Cited by 525
Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1529 · Cited by 517
Wallerian degeneration: the innate-immune response to traumatic nerve injury
Rotshenker, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-109 · Cited by 510
Rock, C. S., & Lowry, S. F. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90146-d · Cited by 503
Interleukin-6 in the Injured Patient: Marker of Injury or Mediator of Inflammation?
Biffl, W. L., Moore, E. E., Moore, F. A., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 502
Le, J., & Vilček, J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_7 · Cited by 474
Self-citationSepsis and cytokines: current status
Blackwell, T. S., & Christman, J. W. (1996) · British Journal of Anaesthesia · doi:10.1093/bja/77.1.110 · Cited by 459
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed
Dinarello, C. A. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225006129 · Cited by 435
Monocyte Cytokine Production in an Elderly Population: Effect of Age and Inflammation
Roubenoff, R., Harris, T. B., Abad, L. W., Wilson, P. W. F., Dallal, G. E., & Dinarello, C. A. (1998) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/53a.1.m20 · Cited by 418
Roubenoff, R., Parise, H., Payette, H. A., Abad, L. W., D'Agostino, R., Jacques, P. F., Wilson, P. W. F., Dinarello, C. A., & Harris, T. B. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.05.001 · Cited by 395
Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke
Tarkowski, E., Rosengren, L., Blomstrand, C., Wikkelsö, C., Jensen, C., Ekholm, S., & Tarkowski, A. (1995) · Stroke · doi:10.1161/01.str.26.8.1393 · Cited by 383
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
van der Poll, T., Levi, M., Hack, C. E., ten Cate, H., van Deventer, S. J., Eerenberg, A. J., de Groot, E. R., Jansen, J., Gallati, H., & Büller, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1253 · Cited by 383
Interleukin‐6 is a significant predictor of radiographic knee osteoarthritis: The Chingford study
Livshits, G., Zhai, G., Hart, D. J., Kato, B. S., Wang, H., Williams, F. M. K., & Spector, T. D. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24598 · Cited by 382
Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular Cells
Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., & Stern, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11463 · Cited by 345
Vallejo, R., Tilley, D. M., Vogel, L., & Benyamin, R. (2010) · Pain Practice · doi:10.1111/j.1533-2500.2010.00367.x · Cited by 333
CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS
van der Poll, T., & van Deventer, S. J. H. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70083-0 · Cited by 323
Induction and regulation of interleukin-6 gene expression in rat astrocytes
Benveniste, E. N., Sparacio, S. M., Gavin Norris, J., Grennett, H. E., & Fuller, G. M. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90104-u · Cited by 314
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
Savale, L., Tu, L., Rideau, D., Izziki, M., Maitre, B., Adnot, S., & Eddahibi, S. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-6 · Cited by 313
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
Böttner, M., Krieglstein, K., & Unsicker, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752227.x · Cited by 301
Impaired neuroglial activation in interleukin-6 deficient mice
Klein, M. A., M�ller, J. C., Jones, L. L., Bluethmann, H., Kreutzberg, G. W., & Raivich, G. (1997) · Glia · doi:10.1002/(sici)1098-1136(199703)19:3<227::aid-glia5>3.0.co;2-w · Cited by 289
Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283
Regulation of cytokine release from mononuclear cells by the iron- binding protein lactoferrin
Crouch, S., Slater, K., & Fletcher, J. (1992) · Blood · doi:10.1182/blood.v80.1.235.235 · Cited by 294
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Tilders, F. J. H., DeRuk, R. H., Van Dam, A.-M., Vincent, V. A. M., Schotanus, K., & Persoons, J. H. A. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90010-8 · Cited by 277
Hagberg, H., Gilland, E., Bona, E., Hanson, L.-Å., Hahn-Zoric, M., Blennow, M., Holst, M., McRae, A., & Söder, O. (1996) · Pediatric Research · doi:10.1203/00006450-199610000-00015 · Cited by 274
IL-6: Insights into Novel Biological Activities
Barton, B. E. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4420 · Cited by 269
Cytokine signaling-regulation of the immune response in normal and critically ill states
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00002 · Cited by 267
Apelt, J., & Schliebs, R. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03176-0 · Cited by 257
Mackowiak, P. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1870 · Cited by 254
LPS and TNFα induce SOCS3 mRNA and inhibit IL‐6‐induced activation of STAT3 in macrophages
Bode, J. G., Nimmesgern, A., Schmitz, J., Schaper, F., Schmitt, M., Frisch, W., Häussinger, D., Heinrich, P. C., & Graeve, L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01662-2 · Cited by 196
IL‐6 and IL‐1β in Fever: Studies Using Cytokine‐Deficient (Knockout) Mice a
KOZAK, W., KLUGER, M. J., SOSZYNSKI, D., CONN, C. A., RUDOLPH, K., LEON, L. R., & ZHENG, H. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08310.x · Cited by 189
Tosun, M., Celik, H., Avci, B., Yavuz, E., Alper, T., & Malatyalioğlu, E. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767051003774942 · Cited by 185
Fantuzzi, G., & Dinarello, C. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.489 · Cited by 156
Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans.
Stouthard, J. M., van der Poll, T., Endert, E., Bakker, P. J., Veenhof, C. H., Sauerwein, H. P., & Romijn, J. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962327 · Cited by 139
Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock
Meng, Z. H., Dyer, K., Billiar, T. R., & Tweardy, D. J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.2.c343 · Cited by 131
Stimulatory effect of antidepressants on the production of IL-6
Kubera, M., Kenis, G., Bosmans, E., Kajta, M., Basta-Kaim, A., Scharpe, S., Budziszewska, B., & Maes, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2003.11.006 · Cited by 126
Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse
Rees, D. D., Monkhouse, J. E., Cambridge, D., & Moncada, S. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701815 · Cited by 86
“Whether IL-6 represents a negative feedback mechanism that downregulates TNF-a production, as has been suggested by results in vitro and in vivo (Aderka et al., 1989), remains to be elucidated.”
Lyons, R. E., Anthony, J. P., Ferguson, D. J. P., Byrne, N., Alexander, J., Roberts, F., & Roberts, C. W. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2589-2595.2001 · Cited by 79
Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach
Upaganlawar, A. B., Wankhede, N. L., Kale, M. B., Umare, M. D., Sehgal, A., Singh, S., Bhatia, S., Al-Harrasi, A., Najda, A., Nurzyńska-Wierdak, R., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112146 · Cited by 53
Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy
Hiskens, M. I., Schneiders, A. G., Angoa-Pérez, M., Vella, R. K., & Fenning, A. S. (2020) · Biomarkers · doi:10.1080/1354750x.2020.1735521 · Cited by 32
A three-dimensional in vitro model to quantify inflammatory response to biomaterials
Parks, A. C., Sung, K., & Wu, B. M. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.07.029 · Cited by 13
“5 ug/mL IL-1b and TNF-a both increase with exposure to PLGA microparticles (not nano-particles) [36] 2D transwell NHDF fibroblasts and human blood derived monocytes PEG siPN or transwell PC membrane GMCSF and MMP-2 are increased in co-culture as compared to monoculture [39] 2D primary human gingival fibroblasts LPS –…”
Background
Metadata
- Authors
- Aderka, D., Le, J., & Vilček, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-12-01
- Volume
- 143
- Issue
- 11
- Pages
- 3517-3523
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2254552946
- Cited by
- 574
- References
- 0
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.